|
|
Volumn 13, Issue 5, 2002, Pages 737-741
|
|
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer
a
|
|
Author keywords
Non small cell lung cancer; Pemetrexed; Phase II
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
GLUTAMIC ACID DERIVATIVE;
GUANINE;
PEMETREXED;
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
DEXAMETHASONE;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
PALLIATIVE THERAPY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
ADVANCED CANCER;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG EFFICACY;
DRUG INFUSION;
DRUG SAFETY;
GASTROINTESTINAL TOXICITY;
HISTOPATHOLOGY;
HUMAN TISSUE;
INFECTION;
LARGE CELL CARCINOMA;
LIVER TOXICITY;
LUNG ADENOCARCINOMA;
MAJOR CLINICAL STUDY;
NEUTROPENIA;
PRIORITY JOURNAL;
RASH;
SKIN TOXICITY;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
GLUTAMATES;
GUANINE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PALLIATIVE CARE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
COMPARATIVE STUDY;
HUMAN;
MIDDLE AGE;
|
|
EID: 0035985288
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf115 Document Type: Article |
|
Times cited : (124)
|
|
References (18)
|
